NCT06164808Recruiting
Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch
Source: ClinicalTrials.gov · Last updated 9 Jun 2026
Brief summary (registry, in English)
Heart rhythm disorders are common and significantly impact the lives of those affected and their families. The main problems can be categorized as: a) atrial fibrillation or AF and atrial flutter, b) supra-ventricular tachycardia or SVT, c) excessively slow heart beats (i.e., bradycardia or pauses) and d) ventricular arrhythmias. These problems can be difficult to detect with currently available monitoring options as they are all worn for shorter terms or are an invasive implantable option. The HeartWatch is a longer term monitoring system that is worn on the upper arm, allows users to create a tag and pairs with an app on a smartphone allowing for correlation of symptoms.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 1 Dec 2023
- Start date
- 20 Feb 2024
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- HelpWear Inc.
- Diseases
- Atrial fibrillation
- NCT number
- NCT06164808
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 20 Feb 2024 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Inability to wear the HeartWatch on the left arm for the study period due to pre-existing medical condition (3.g., functional AV fistula in left arm, prior carcinoma with lymph node dissection or lymphedema, known blood clot of recurrent blood clots in the left arm, chronic neuropathic pain in left arm, ...)
Other illness
- Known allergy to any component of the Holter monitor
- Known allergy to any component of the HeartWatch
Other
- Dextrocardia
- Implanted functional Pacemaker or Defibrillator
- Left bicep circumference \< 22 cm
- Left bicep circumference \< 45 cm
Who the study is looking for
- At least 22 years of age at time of consent
- Clinically indicated for a Holter monitor test
- Able to wear the HeartWatch on the left bicep for the study duration
- Able to follow the protocol
- No functional implantable pacemaker or defibrillator
- Left bicep circumference \>/= 22 cm and \</= 45 cm
- Provision of written-informed consent
Age in the registry: 22 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Foothills Medical Centre University of Calgary Coordinator of this site? Confirm its status | Calgary | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.